person

Gabriel L.

Country
Sweden
Department
Onkologiska kliniken

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
121
Sites with multiple studies

Has run more than one trial at 121 of 245 partner sites.

Specializations

Gynecologic Oncology

The investigator specializes in treating various forms of gynecologic cancers, with particular emphasis on endometrial cancer management. Their research encompasses both advanced and recurrent disease states, focusing on novel therapeutic approaches including targeted maintenance therapies.

  • Advanced Endometrial Cancer
  • High-Risk Early-Stage Disease
  • Post-Surgical Treatment Strategies

Their work includes evaluation of innovative treatment combinations incorporating immunotherapy and standard chemotherapy protocols.

Ovarian Cancer Research

The investigator conducts research in ovarian cancer treatment, particularly focusing on maintenance therapy approaches and biomarker studies. Their expertise extends to both early-stage interventions and advanced disease management.

  • Epithelial Ovarian Cancer
  • Maintenance Therapy Strategies
  • Biomarker Assessment

Their research includes innovative combination approaches utilizing immunotherapy and targeted agents for recurrent disease.

Cervical Cancer Treatment

The investigator explores treatment options for recurrent and metastatic cervical cancer, with particular focus on second-line therapy development. Their research addresses the challenges of treatment-resistant disease.

  • Advanced Cervical Cancer
  • Post-Immunotherapy Treatment
  • Novel Therapeutic Approaches

Their work includes evaluation of new therapeutic agents for patients who have progressed after standard treatments.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.